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Background:  In  studies  exploring  the  effects  of HCMV  infection  on  immune  system  aging  (‘immunose-
nescence’),  after  organ  transplantation  or in  other  settings,  HCMV-speciﬁc  T-cell  responses  are  often
assessed  with  respect  to purportedly  ‘immunodominant’  protein  subunits.  However,  the  response  struc-
ture in  terms  of  recognized  antigens  and  response  hierarchies  (architecture)  is not well  understood  and
actual correlates  of  immune  protection  are  not  known.
Methods:  We  explored  the  distribution  of T-cell  response  sizes  and  dominance  hierarchies  as  well  as
response  breadth  in 33  HCMV  responders  with  respect  to >200  HCMV  proteins.
Results:  At the individual  responder  level  HCMV-speciﬁc  T-cell  responses  were  generally  arranged  in clear
dominance  hierarchies;  interestingly,  the  number  of  proteins  recognized  by an  individual  correlated
closely  with the  size  of  their  biggest  response.  Target-speciﬁcity  varied  considerably  between  donors
and  across  hierarchy  levels  with  the  presence,  size,  and  hierarchy  position  of responses  to purportedly
‘immunodominant’  targets  being  unpredictable.
Conclusions:  Predicting  protective  immunity  based  on isolated  HCMV  subunit-speciﬁc  T-cell  responses
is questionable  in  light  of the  complex  architecture  of the  overall  response.  Our  ﬁndings  have  important
implications  for  T-cell  monitoring,  intervention  strategies,  as well  as  the application  of animal  models  to
the  understanding  of human  infection.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Large human CMV  (HCMV)-speciﬁc T-cell responses have been
escribed in numerous published reports, particularly in the trans-
lantation setting and older life (Kern et al., 2002; Ouyang et al.,
003, 2004; Sester et al., 2002; Sylwester et al., 2005; Vescovini
t al., 2007). These conspicuous responses are often thought to
pearhead T-cell immunity to HCMV and many researchers believe
hey grow so large because this is a requirement for protec-
ion. Another reason, however, might be the life-long persistence
f latent HCMV infection with frequent episodes of reactivation
hat gradually but steadily increase response size (Fletcher et al.,
005; Moss, 2010). Expanded CMV-speciﬁc T-cell populations in
∗ Corresponding author at: Brighton & Sussex Medical School, Medical Research
uilding, Biology Road, Brighton BN1 9PX, United Kingdom.
E-mail address: f.kern@bsms.ac.uk (F. Kern).
ttp://dx.doi.org/10.1016/j.mad.2016.03.002
047-6374/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).humans have been modeled in the mouse using murine CMV
(MCMV) infection, where longitudinal studies have observed the
phenomenon termed memory ‘inﬂation’(Holtappels et al., 2000;
Lang et al., 2009; Lang and Nikolich-Zugich, 2011; O’Hara et al.,
2012; Snyder et al., 2011). ‘Inﬂation’ in this context, although
not formally deﬁned, refers to (delayed) expansion and long-term
maintenance of speciﬁc T-cell populations after initial infection.
Interestingly, however, removal of a highly dominant MCMV-
speciﬁc T-cell response in the BALB/c model has shown that these
responses are not necessarily required to control infection but that
smaller responses may  take on this role even without expansion
(Holtappels et al., 2008). It still remains unclear to what extent these
observations are applicable to humans.
Since in humans the duration of HCMV infection is usually not
known, monitoring the development of T-cell responses beginning
at the time of infection is not possible except in the not entirely
compatible setting of organ transplantation (Hertoghs et al., 2010).
Numerous human studies have used cross-sectional designs using
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Fig. 1. CD8 T-cell immunity to four exemplar proteins shows multiple ‘inﬂated’ responses (statistical outliers) across the population.
Large CD8 T-cell expansions are found with respect to most CMV  target proteins. Dotted horizontal lines indicate the upper limit above which responses are considered
outliers (upper quartile + 1.5 × inter quartile range, non-parametric deﬁnition). Note the differences in y-axis scaling in each diagram. IFN- responses are shown. The
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cxamples illustrate considerable differences in response ‘levels’ in regards to differ
onors  in all ﬁgures.
ifferent age groups to investigate changes of HCMV speciﬁc immu-
ity over time, however, this approach cannot easily distinguish the
ffects of immune aging from those of the duration of HCMV infec-
ion (Alp et al., 1991; Borysiewicz et al., 1988; Fletcher et al., 2005;
ibson et al., 2004; Khan et al., 2004; Lachmann et al., 2012; Ouyang
t al., 2003, 2004; Weekes et al., 1999). Interestingly, very large
CMV-speciﬁc responses were described both in older and young
opulations (Komatsu et al., 2006, 2003), indicating that response
nﬂation is not a direct function of chronological age.
Most human studies have investigated CD8 T-cells speciﬁc to
iral subunits, such as the HCMV UL83 (‘pp65’) and UL123 (‘IE1’)
roteins (Bunde et al., 2005; Kern et al., 1999; Lachmann et al.,
012; Moss and Khan, 2004). Often select UL83-derived peptides
ere used, such as NLVPMVATV, presented by HLA-A*0201 or
PRVTTTGAM, presented by HLA-B7*0702 (Gibson et al., 2004; Khan
t al., 2004; Ouyang et al., 2003, 2004). Both peptides frequently
nduce robust, sometimes exceptionally large responses, and the
igh frequencies of HLA-A*0201 and HLA-B7*0702 are very conve-
ient for studies in white American and European populations (Cao
t al., 2001).
Despite many advances, a breakthrough in terms of HCMV-
peciﬁc T-cell response monitoring beyond the detection of
ost-transplantation immune reconstitution has not been achieved
o date (Borchers et al., 2014). While the technological basis for
onitoring HCMV-speciﬁc T-cells has existed since roughly the mid
990s (Altman et al., 1996; Picker et al., 1995; Waldrop et al., 1997),
orrelates of protection remain undeﬁned. This is owed largely tooteins and different donors. Donors are shown as ‘Dx’ where x identiﬁes identical
the fact that we lack a clear understanding of the structural com-
position of this response.
A study published by us in 2005 showed a surprisingly wide
spectrum of HCMV-speciﬁc T-cell target selection across a popu-
lation sample of 33 CMV-infected healthy donors; CD8 and CD4
T-cell responses to 213 HCMV proteins were tested. This study
provided novel, fundamentally important information such as a
complete list of proteins recognized by CD8 and CD4 T-cells, the
most frequently recognized ones, and the most dominant ones (by
summated response size) (Sylwester et al., 2005). However, this
dataset contained a wealth of additional information that was not
extracted at the time of publication. In particular it was  uniquely
suited for studying the architecture of the HCMV-speciﬁc T-cell
response in terms of the relationships between response numbers,
sizes, hierarchy levels, and target speciﬁcities, both in individuals
and across the population. Here we  present a new, differential anal-
ysis of this dataset devised to improve our understanding of the
blueprint of this response.
Our new analysis shows that in the vast majority of individuals
multiple T-cell responses to HCMV are organized in ﬁnely graded
dominance hierarchies with highly variable target speciﬁcity at
each hierarchy level. In addition there is a striking positive asso-
ciation between the number of recognized target proteins in each
individual and the size of their biggest response, associating the
presence of many responses with the presence of large responses.
Despite overall structural complexity, and hugely different levels
of response size, the basic response architecture was surprisingly
similar in different individuals. This novel insight should inform the
16 A. Sylwester et al. / Mechanisms of Ageing and Development 158 (2016) 14–22
Table  1
Non-inﬂated versus inﬂated CMV  T-cell responses shown for proteins inducing responses in at least four donorsa and for donors responding to at least four proteinsa.
T-cell Subset Analysis by No. responses analyzed No. of donors in analysis No. proteins in analysis No. of inﬂated responses (outliers in%)
CD8 Protein 250 33 33 26 (10.4%)
Donor 368 28 107 44 (11.9%)
CD4  Protein 230 33 20 29 (12.6%)
Donor 494 31 125 51 (10.3%)
a Minimum number of responses for applying outlier deﬁnition.
Table 2
Breakdown of inﬂated T-cell responses (outliersa) by protein kinetic class, shown for proteins inducing responses in at least four donorsb and for donors responding to at
least  four proteinsb.
Protein kinetic class Nr. of proteins with outliers Nr. of outliers Found in (Nr. of individuals) average/max size of outliers (% of T-cells)
CD8/per protein IE 2 5 5/33 10.0/14.4
E  3 3 3/33 1.9/2.2
E-L  5 6 4/33 2.6/3.5
L  4 9 7/33 6.1/14.3
Not  assigned 4 3 3/33 3.2/4.8
CD8/per individual IE 5 14 12/28 6.4/14.4
E  3 4 4/28 2.7/6.1
E-L  5 7 7/28 2.1/3.5
L  9 15 11/28 5.0/14.3
Not  assigned 3 4 4/28 6.4/13.7
CD4/per protein IE 2 2 1/33 2.7/2.9
E  6 9 9/33 3.7/8.5
E-L  5 9 8/33 2.7/7.1
L  5 7 5/33 3.1/6.9
Not  assigned 2 2 2/33 2.3/2.8
CD4/per individual IE 3 3 3/31 1.7/2.3
E  5 16 14/31 2.9/8.5
E-L  5 10 7/31 3.9/9.6
L  6 21 14/31 2.8/7.6
Not  assigned 1 1 1/31 1.9/1.9
a Outliers were deﬁned as values >(upper quartile + (1.5 × inter-quartile range)).
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easurement and interpretation HCMV-speciﬁc T-cell responses in
esearch and clinical settings and it should be interesting to estab-
ish if it holds true for T-cell responses to other types of antigens.
. Materials and methods
.1. Participants
The original study was carried out in Portland/Oregon, USA
nd approved by the Institutional Review Board of Oregon Health
nd Science University. The study was conducted according to the
eclaration of Helsinki; all participants gave written informed con-
ent. It included 33 CMV+ healthy individuals of various ethnic
ackgrounds (white Caucasian, black African and Asian), between
9 and 53 years of age. Additional relevant details are published
Sylwester et al., 2005).
.2. Blood samples and activation assays
Blood samples were obtained by apheresis and anticoagulated
ith sodium-heparin. PBMC were prepared according to stan-
ard protocols and cryopreserved as reported in detail elsewhere
Sylwester et al., 2005). Brieﬂy, thawed or fresh PBMC were incu-
ated with sets of CMV  protein-spanning peptide pools for 1 h
efore addition of Brefeldin A (‘BFA’, Sigma, St. Louis, MO), then
ncubated at 37C (standard incubator) for additional 5 h (ﬁnal vol-
me  of 1 ml)  in the presence of co-stimulatory antibodies, CD28
nd CD49d (BD Biosciences). Following incubation, cells were har-vested in PBS and surface stained, ﬁxed and lysed with FACS Lysing
solution (BD Biosciences), permeabilized with BD Permeabilizing
solution (BD Biosciences), washed and stained with ﬂuorochome-
labeled antibodies for intracellular IFN- and/or other activation
markers.
2.3. Protein selection and peptide pools
A total of 191 ORF sequences were sourced from the AD
169 laboratory strain sequence; an additional 22 sequences were
added from the Toledo and Towne strains. Sequence data were
obtained from GenBank/EMBL/DDBJ (protein database) site and
from the SWISS-PROT database. Consecutive 15mer peptides, over-
lapping by 10 or 11 amino acids, were synthesized for each
protein sequence using solid-phase peptide synthesis methods,
employing an Fmoc synthesis strategy (Mimotopes Pty., Ltd.). All
peptides had free acid C-termini and free amine N-termini. Peptides
associated with each CMV  protein were pooled and stored in freeze-
dried aliquots at −80 ◦C. Prior to usage, freeze-dried aliquots were
dissolved in DMSO. Final peptide concentrations were 2 g/ml.
Additional details were published previously (Sylwester et al.,
2005). The assignment of protein kinetic classes was  adopted from
the historical study (Sylwester et al., 2005) and indicates the time
after viral reactivation at which certain proteins are expressed,
including immediate early (IE), early (E), early-late (EL), late (L),
and non-classiﬁed (NC) (Chambers et al., 1999).
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Fig. 2. The repertoire of targeted proteins in different individuals is highly variable.
(A) CD8 and CD4 T-cell responses in two  representative donors, D25 (donor 25) and D29 (donor 29) are shown. Multiple target proteins are recognized at different dominance
hierarchy levels. Note that in D25 the CD8 response is small compared to the CD4 response but the opposite is true in D29. Large differences in response size between the
two  subsets were frequently observed. Columns show non log-transformed background-subtracted responses. Donors are shown as ‘Dx’ where x identiﬁes identical donors
in  all ﬁgures. (B) Following standardization of response sizes using the Z-score calculated as Z-score (z) = (X-)/, where X is a measured value,  is the arithmetic mean
of  all measured values, and  is the standard deviation. The maximum Z-score (‘Max Z-score’) for each individual was plotted against their corresponding response count.
Values  outside the mean + 2 standard deviations (SD) were deﬁned as ‘inﬂated responses’ or outliers with respect to individual response levels according to our deﬁnition. The
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.4. Flow-cytometric analysis
Data ﬁles were analyzed using the PAINT-A-GATE Plus soft-
are program (BD Biosciences), as described previously (Sylwester
t al., 2005). Brieﬂy, T-cell populations (CD4+ or CD8+) were
ated from lymphocytes deﬁned by scatter parameters, and viewed
gainst IFN- expression in 2D dotplots in order to identify posi-
ive events. Responses were expressed in percent of the respective
eference population. Background determined from unstimulated
amples (no peptide added) was subtracted. To rule out any
purious responses, only net CD4 responses >0.06% and net CD8
esponses >0.08% were counted as positive; the algorithm used
o establish these thresholds is described in detail elsewhere
Sylwester et al., 2005).
.5. Statistical analysis
Tests for the normality of distribution, parametric and non-
arametric tests, and multiple regression analysis were performed
sing SPSS 20.0 (IBM, Portsmouth, UK). T-cell response standardiza-
ion was performed on log-transformed data. Z-scores, also known
s standard scores (z) were calculated as z = (X-)/, where X
s a measured value,  is the arithmetic mean of all measured
alues, and  is the standard deviation. Deﬁnitions used for sta-
istical outliers were as follows: (i) values greater than the upper
uartile + 1.5 × the inter-quartile range (non-parametric) and (ii)
alues greater than the arithmetic mean + 2 standard deviationson from the mean is a function of response breadth, i.e., the number of recognized
ar) are shown in (B) and (C) and the Pearson correlation coefﬁcient (r) is provided
(SD) (parametric); when using parametric deﬁnitions T-cell per-
centages were log-transformed.
3. Results
3.1. CMV  protein immunodominance is unpredictable in healthy
individuals
To begin, we sought to identify immunodominant HCMV anti-
gens that consistently generated large or very large responses in
healthy HCMV+ people. The distribution of CD8 and CD4 T-cell
responses to 213 HCMV proteins in 33 donors was visualized in
a heat map-like format in order to provide an overview of response
numbers, sizes, and target selection (see Supplementary Figs. S1
and S2 in the online version at DOI: 10.1016/j.mad.2016.03.002). All
responses classiﬁed positive as per the original report (Sylwester
et al., 2005) were used in this and subsequent analyses. The most
dominant antigens varied considerably between donors and in
regards to kinetic class. Responses ranged from barely detectable
to double ﬁgure percentages, with the full spectrum of response
sizes often present in the same individuals. There were no signiﬁ-
cant gender differences with respect to the number of recognized
target proteins or summated responses.
Most responders recognized 5–10 CMV  proteins within each
T-cell compartment. Mapping all responses down to the level of
single peptides was beyond the scope of the study, however, in
light of our previous observation that protein-speciﬁc responses
are usually dominated by single epitopes, this would suggest that
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Fig. 3. The bigger the response count the higher is the frequency of responses representing statistical outliers.
Response counts were plotted against the Z-scores of log-transformed CD4 and CD8 T-cell responses in each individual. A positive correlation between sample size and number
of  outliers is expected if the response distribution is based on a normal distribution. Protein kinetic classes are color-coded (IE = Immediate Early, E = Early, E-L = Early-Late,
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esponders recognize 5–10 major epitopes (Kirchner et al., 2008).
n order to address the size of these responses systematically we
rst compared T-cell responses to the same protein in different
esponders, separately for CD8 and CD4 T-cells.
For CD8 T-cells this analysis was limited to 33 proteins recog-
ized by at least four responders in order to allow the application
f statistical outlier deﬁnitions as a working model for ‘inﬂated’
esponses (i.e., identifying expansions outside the expected range
f responses). In this context, “inﬂation” is taken to represent those
esponses that show an extreme phenotype among the popula-
ion. In studies of mice, a broader deﬁnition may  be used based on
ongitudinal measurements post-infection, assessment of surface
arker expression and tissue distribution, which might include a
umber of different patterns of responsiveness and a wide range of
requencies (Munks et al., 2006a).
CD8 T-cell responses to the same protein varied widely in size
etween donors and the threshold for calling a large response an
utlier (i.e., ‘inﬂated’) ranged from 0.33 to 10.57% of CD8 T-cells,
epending on the protein (Fig. 1). Such outliers accounted for 10.4%
f all responses (Table 1). We  then reversed this approach by ana-
yzing the responses to the proteins recognized in each individual
same responder, different proteins). Here, the threshold for calling
arge responses outliers ranged from 0.52 to 4.82% of CD8 T-cells, be the preferred targets of CD8 T-cell response outliers, Early, Early-Late and Late
reviously published. Donors are shown as ‘Dx’ where x identiﬁes identical donors
depending on the responder (28 individuals recognizing four or
more proteins were included). The proportion of outliers was in the
same order of magnitude as in the ﬁrst analysis (Table 1), but more
importantly, the proteins recognized by the largest T-cell responses
in each responder varied considerably. This conﬁrmed that HCMV
protein immunodominance is not predictable in healthy humans,
and agrees with our more limited, earlier ﬁnding that UL83 and
UL123 epitope immunodominance cannot be predicted even if the
individual HLA-type is considered (Kirchner et al., 2008). The anal-
ysis of CD4 T-cell responses provided very similar results (Table 1).
The threshold for calling large CD4 T-cell responses outliers ranged
from 0.22 to 13.93% for different proteins (across all responders),
and from 0.41 to 4.31% for different responders (across the proteins
recognized by each). Additional details are provided in Table 2.
3.2. Different individuals display similar response distributions
but different response levels
In the same individuals, the maximum response sizes of CD8
and CD4 T-cells were often very different, up to an order of mag-
nitude (Fig. 2A). The response levels in each T-cell compartment
were highly variable across the population. We,  therefore, stan-
dardized response size in order to compare response distributions.
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Fig. 4. Maximum response size is related to the number of recognized proteins.
(A) Response sizes across the whole population sample (log-transformed percentages) were standardized using the Z-score (z) = (X-)/, where X is a mea-
sured  value,  is the arithmetic mean of all measured values, and  is the standard deviation. Z-scores were categorized (48 bins) to facilitate the visualization
of  response size distributions. Diagrams show a large predominance of small and medium sized responses (smaller Z-scores), suggesting these responses
constitute the backbone of HCMV-speciﬁc T-cell immunity. A total of 377 Z-scores were included for CD8, and 499 Z-scores for CD4 responses. (B) Both
CD8  (left) and CD4 (right) response sums (in% of the reference subset, ﬁlled circles) correlate signiﬁcantly with the number of responses in each individual
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(0 A. Sylwester et al. / Mechanisms of A
-scores were calculated for all responses in all individuals (i.e., for
ach response its deviation from the mean was expressed in mul-
iples of the SD). Interestingly, increasing response counts were
igniﬁcantly associated with higher Z-scores and increasing num-
ers of outliers (i.e., Z-scores >2) (Fig. 2B). A more detailed view of
-scores by protein target is provided in Fig. 3. To visualize an ‘over-
ll response distribution’ (i.e., at the population level) we  binned
esponses of similar Z-score, revealing a clear predominance of
mall responses and a sharp decline of response frequencies with
ncreasing response size in both CD4 and CD8 T-cells (Fig. 4A).
To further explore an association between the number of pro-
eins recognized in each individual and absolute response size,
e considered summated and average responses (sum of all
rotein-speciﬁc responses in each individual) as well as maximum
esponses. Summated response correlated signiﬁcantly with the
umber of recognized proteins, however, average responses were
nexpectedly similar across the donor population (Fig. 4B). At the
ame time there was a striking and signiﬁcant correlation between
he number of recognized proteins in each participant and the size
f their maximum response (Fig. 4C).
Of note, the historical study identiﬁed a subset of 15 ‘most dom-
nant’ proteins for CD8 T-cells and 6 ‘most dominant’ proteins for
D4 T-cells, the summed response to which correlated highly with
he respective summed response to all proteins. Interestingly, the
ssociation between the number of recognized proteins and the size
f the maximum response was preserved for these subsets of pro-
eins, albeit somewhat weaker (rs = 0.554, p = 0.001 for CD8 T-cells,
5 proteins; rs = 0.508, p = 0.003 for CD4 T-cells, 6 proteins).
.3. HLA-type is signiﬁcantly related to response levels
Because of the great differences in response levels between indi-
iduals, we explored the effect of HLA type on T-cell response
ize using the available typing data (2-letter code). The number
f observations was relatively small for this type of analysis how-
ver, associations between the presence of the most frequent HLA
olecules in the cohort and summed response size were explored.
ogistic regression using stepwise inclusion of HLA types with
t least two respondents revealed that HLA-B7 was  associated
ith the biggest summed responses (p < 0.001) (see Supplemen-
ary Fig. S3 in the online version at DOI: 10.1016/j.mad.2016.03.
02). While these results should be considered preliminary because
f the small response size, the ﬁndings are in agreement with our
revious observation that individuals who were HLA-B7, HLA-B8,
r HLA-A1 positive had signiﬁcantly larger responses to UL123
han individuals with none of these HLA allomorphs (Kern et al.,
000). In addition, individuals having the following phenotypes
howed signiﬁcantly greater maximum responses than the rest,
LA-B7 (p = 0.002), HLA-B56 (p = 0.002), HLA-A1 (p = 0.006), and
LA-A23 (p = 0.002) (not shown). Supplementary Table S1 pro-
ides an overview of summed response sizes by donor and all
LA-allomorphs present in at least two people.
. Discussion
Our analysis integrates individual population-based proﬁles of
esponse counts, sizes, hierarchies, and target speciﬁcities, to cre-
te a uniquely comprehensive picture of the structural ‘scaffold’
ehind HCMV-speciﬁc T-cell immunity. Statistical outlier deﬁni-
ions were used as an objective way to identify ‘inﬂated responses’
hereas the normalization of response sizes allowed us to compare
‘response count’). However, the average response size (empty circles) in each compartm
). (C) The size of the biggest CD8 (left) and CD4 (right) response in each individual (‘Ma
linear)  are shown in (B) and (C) and the Spearman-Rank correlation coefﬁcient (rs) is proand Development 158 (2016) 14–22
their distribution across the population despite different individual
response levels.
With many responses per individual, generally organized in
ﬁnely graded hierarchies, the response to CMV  in humans appeared
clearly less polarized than shown in mouse models (Munks et al.,
2006a; Northﬁeld et al., 2005; Snyder et al., 2011). This is probably
due to the outbred human MHC  allowing the presentation of many
more peptides resulting in different degrees of expansion in paral-
lel and more than one inﬂated response. Response hierarchies had
a similar architecture throughout the responder population, the
smallest response being generally just above the detection thresh-
old, irrespective of the size of the maximum response. Response
size standardization (Z-scores) allowed us to compare response
size distributions across the population, irrespective of individual
response level. The observed distribution of response sizes cor-
roborated the ﬁnding that, generally, the biggest responses are
underpinned by numerous very small, small, and medium size
responses rather than existing as isolated peaks. This ﬁtted well
with the observation that the size of the maximum response could
be different by an order of magnitude between some but the aver-
age response size was  almost the same in all individuals (with many
small responses reducing the effect of very large responses on the
average). The fact that the size of the maximum response correlated
with the number of protein-speciﬁc responses in each individual
also ﬁts well with this explanation. Assuming that HCMV-speciﬁc
T-cell responses expand as a function of time after infection, this
might suggest that very small responses, initially below the detec-
tion threshold, become detectable over time. However, this would
have to be addressed in a separate, longitudinal study.
The overall response architecture featuring a broad base of
small and medium responses might provide robustness and ﬂex-
ibility to the recognition of epitopes (Naumov et al., 2003) and is
more likely to be a guarantor of sustained, protective immunity
than the presence of isolated inﬂated responses. It would be very
interesting to study if a similar response architecture is present
in T-cell responses to other infectious agents, tumor antigens, or
self antigens, and whether there is an association between certain
structural features and protective immunity.
Two reports by Ouyang et al. (2003, 2004) described large,
isolated, epitope-speciﬁc responses in healthy older people and
argued that such responses might be critical for controlling HCMV
and continue to grow bigger as a result of diminished response
‘quality’ (suggesting more of these cells are required to do the
same job) (Ouyang et al., 2003, 2004). By contrast, our analysis
shows that individuals with very large responses usually have many
additional responses, underscoring the advantage of studying mul-
tiple speciﬁcities simultaneously. The individuals studied in the
aforementioned reports were on average a lot older than the old-
est individuals in our study, leaving the possibility that signiﬁcant
changes might affect the TCR repertoire during older age. Never-
theless, Ouyang et al. did not look for other responses and our
own  current research suggests that many responses can be found
even in very old people (manuscript in preparation). It is interesting
in this context that experiments in BALB/c mice showed that the
most immune-dominant responses are not required for protection
(Holtappels et al., 2008).
Finally, our preliminary data with respect to MHC types
and response size argue that there is a contribution of certain
HLA-allomorphs to determining the magnitude of responses, con-
ﬁrming previous observations limited to UL83 and UL123 (Kern
et al., 2000). There is limited scope for addressing this question in
ent (all proteins, all donors) was very similar across individuals (compare 3 B and
x. response’) also correlated signiﬁcantly with the response count. Lines of best ﬁt
vided. The signiﬁcance threshold was  set at p < 0.05.
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nbred mouse models. On the other hand, it is known that genetic
actors other than MHC  type contribute signiﬁcantly to T-cell
esponse size in MCMV  models. A comparison between C57BL/6
ice and two other strains, 129/SvJ and BALB.B (both share the hap-
otype, H-2b, with the former but differ in their non-MHC genes)
ound that all strains responded to the same set of epitopes, but
esponse sizes and hierarchies differed signiﬁcantly between them
Munks et al., 2006b). Such an experiment would be difﬁcult to con-
uct in an outbred human or animal population and underlines a
trength of inbred mouse models.
In summary, our data demonstrates that HCMV-speciﬁc
-cell immunity cannot be assessed representatively by test-
ng a few, arbitrarily selected, epitope-speciﬁc responses, for
xample by using single antigenic peptides for stimulation or
taining with MHC-multimers based on the presence of cer-
ain, common HLA-types. A meaningful quantitative comparison
f HCMV-speciﬁc T-cell responses between different individuals
even if sharing one or more HLA alleles) would clearly have to
over many target proteins. More diverse, outbred animal models
ight better reﬂect human diversity in future, and the measure-
ent of broader responses within such models will help dissect
he features underlying T-cell response evolution.
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